1st Quarter - Report — MR. CARL SCHMID for AIDS INSTITUTE (2019)

Firm

MR. CARL SCHMID

Client

AIDS INSTITUTE

Income

$27,500

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part D, including 6 protected classes, Medicaid funding, Medicaid repeal and replace efforts, Medicaid drug coverage, including Hepatitis C drugs. Medicare and Medicaid coverage of preventive services, including HIV and Hepatitis testing. Medicaid waivers

Lobbyist	Covered position, as disclosed
CARL E SCHMID	—

Contacted: Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); White House Office; Executive Office of the President (EOP)

Budget/Appropriations BUD

HIV/AIDS Domestic Programs: Ryan White HIV/AIDS Program, including the AIDS Drug Assistance Program, CDC HIV prevention programs, NIH AIDS Research, HOPWA AIDS housing, Ending the HIV Epidemic Initiative, Minority AIDS Initiative programs. Hepatitis Programs: CDC hepatitis Division, syringe service programs, infectious diseases programs associated with injection drug use and the opioid epidemic

Lobbyist	Covered position, as disclosed
CARL E SCHMID	—

Contacted: Executive Office of the President (EOP); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Natl Institutes of Health (NIH); SENATE

Health Issues HCR

HIV/AIDS Domestic Programs: Ryan White HIV/AIDS Program, including the AIDS Drug Assistance Program, HIV prevention including HIV testing and syringe services, AIDS housing, healthcare reform, including essential health benefits, high patient cost-sharing, copay assistance and plan design discrimination. health care repeal and replace, hepatitis programs at CDC and HHS; programs addressing infectious diseases associate with the opioid epidemic related to injection drug use. Ending HIV Epidemic Initiative

Lobbyist	Covered position, as disclosed
CARL E SCHMID	—

Contacted: Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.